Skip to main content
Caplight Logo









KeyWise AI

KeyWise AI

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://keywise.tech

Last Round

Seed

Jun 28, 2022

Company Overview

KeyWise AI operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Seed round in June 2022.

KeyWise AI is a healthcare technology company that provides an AI-based platform to measure brain health and cognitive performance by analyzing smartphone keystroke behavior.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

KeyWise AI Comparables

Compare KeyWise AI with similar companies based on industry and business-model similarity.

KeyWise AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Behavidence
87%
Accexible
77%
LangAware
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

KeyWise AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 28, 2022
SeedApr 1, 2022
GrantJan 23, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Olu Ajilore

Co-Founder And Chief Medical Officer

Founding Team

For institutional investors. Book with your work email.

KeyWise AI Investors

Notable investors and investment history

Book a demo to see all 10 investors

For institutional investors. Book with your work email.

KeyWise AI Filings

Explore SEC and related filing metadata, where available.

KeyWise AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about KeyWise AI's valuation, stock price, and market status.

Is KeyWise AI a public or private company?

KeyWise AI is a private company.

What is the current stock price of KeyWise AI?

KeyWise AI is a private company, so its shares have no public market price. Caplight tracks KeyWise AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is KeyWise AI worth (valuation)?

Valuation information for KeyWise AI is not publicly available.

Can I buy KeyWise AI stock?

KeyWise AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was KeyWise AI's last funding round?

KeyWise AI's most recent funding round was Seed on June 28, 2022.

Who are the main investors in KeyWise AI?

Key investors in KeyWise AI include NIH RADx, 11 Tribes Ventures, National Institute on Aging, TSV Capital, Joyance Partners.

Will KeyWise AI IPO soon?

No public IPO plans have been announced for KeyWise AI.

How can I track KeyWise AI secondary market activity?

Caplight tracks bids, offers, and trades in KeyWise AI's shares on secondary markets.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range4
Year Founded2019
Last FundingJun 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?